Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dual specificity antibodies using a double-stranded oligonucleotide bridge.

Z N Chaudri1, M Bartlet-Jones, G Panayotou

  • 1Department of Immunology, University College London, The Windeyer Institute for Medical Sciences, UK.

FEBS Letters
|June 1, 1999
PubMed
Summary

Researchers optimized bispecific antibody generation using complementary oligonucleotides linked to antibody fragments. This novel method enables precise antibody pairing for versatile molecular linking applications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cellular Vesicles: New Insights in Engineering Methods, Interaction with Cells and Potential for Brain Targeting.

The Journal of pharmacology and experimental therapeutics·2019
Same author

Investigation of factors influencing the immunogenicity of hCG as a potential cancer vaccine.

Clinical and experimental immunology·2018
Same author

Autophagy activation is required for influenza A virus-induced apoptosis and replication.

Biochimica et biophysica acta. Molecular cell research·2017
Same author

Lipoxin A<sub>4</sub> selectively programs the profile of M2 tumor-associated macrophages which favour control of tumor progression.

International journal of cancer·2016
Same author

Comparing a thyroid prognostic nomogram to the existing staging systems for prediction risk of death from thyroid cancers.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2016
Same author

Autophagy is a regulator of TGF-β1-induced fibrogenesis in primary human atrial myofibroblasts.

Cell death & disease·2015

Area of Science:

  • Bioconjugation Chemistry
  • Molecular Biology
  • Immunotechnology

Background:

  • Antibody engineering is crucial for developing targeted therapies and diagnostic tools.
  • Bispecific antibodies offer enhanced specificity by binding to two different targets simultaneously.
  • Efficient conjugation strategies are needed to create complex antibody formats.

Purpose of the Study:

  • To optimize the covalent conjugation of oligonucleotides to antibody Fab' fragments.
  • To develop a method for generating bispecific antibodies through oligonucleotide hybridization.
  • To demonstrate the versatility of this approach for linking diverse molecules.

Main Methods:

  • Oligonucleotides were modified with a hexaethylene linker arm containing three amino groups.

Related Experiment Videos

  • Complementary oligonucleotides were covalently coupled to antibody fragments of distinct specificities.
  • Antibody hybridization was achieved via base pairing of the conjugated oligonucleotide sequences.
  • Bispecific antibody generation was analyzed using SDS-PAGE and confirmed with BIAcore analysis.
  • Main Results:

    • Optimized conjugation yielded functional antibody-oligonucleotide conjugates.
    • Successful generation of bispecific antibodies through complementary oligonucleotide hybridization was achieved.
    • SDS-PAGE and BIAcore analysis confirmed the formation and binding characteristics of the bispecific antibodies.

    Conclusions:

    • A robust method for creating bispecific antibodies using oligonucleotide linkers was established.
    • This strategy provides a versatile platform for linking various molecular entities, not limited to antibodies.
    • The approach holds potential for applications in targeted drug delivery, diagnostics, and molecular assembly.